• Managed the local QRVI team (coordination and supervision, resources and budget, etc.)• Acted as the key contact person in regional critical issues and regional crisis management, in close partnership with the Corporate• Obtained a priority review for a strategic drug in the Middle East market • Analyzed local regulatory legislations for Middle East countries and developed local regulatory strategies• Organized two regional QRVI seminars gathering different stakeholders from Middle East and Europe• Achieved successful GMP (Good Manufacturing Practices) audit visits from different health authorities to Pierre Fabre and subcontracted manufacturing sites in France and Italy. • Implemented a local Quality Management System and a local quality electronic documentation database and trained colleagues.• Implemented a medical information reporting system in the region• Active member of a working group « Cosmetics Europe Interested Parties Group – Middle East North Africa (IPG MENA) » gathering 21 international companies, established by Cosmetics Europe and coordinated by the French Industry Association (FEBEA)

• Established the regulatory and pharmacovigilance department in Pierre Fabre Beirut • Managed a portfolio of more than 200 drugs and 2000 products from different categories (cosmetics, food supplements, medical devices, etc.) in 13 Middle East countries • Handled more than 30 business partners in the region • Accomplished key products (all categories) registration in strategic markets • Reviewed and assessed several contracts (Registration Agreements, Safety Data Exchange Agreements and Quality Agreements) with business partners and overviewed their implementation• Implemented a vigilances (pharmacovigilance, cosmetovigilance, nutrivigilance, etc.) reporting system and trained over 100 colleagues in the region.• Participated to more than 15 pharmacovigilance audits with business partners all over the region and followed CAPA’s (Corrective Actions Preventive Actions) implementation.

Prepared module 3 (quality module - CTD dossier) of registration dossiers in collaboration with technical units.•Answered technical questions from various Health Authorities worldwide.•Prepared variation and renewal documents for licence maintenance of several OTC products in Europe and Rest Of the World (ROW) countries.

•Pharmacy intern rotated in several units (cardiology, pneumology, gastrology, infectious diseases, oncology, intensive care unit, pediatrics and the hospital’s pharmacy)• Monitored several pharmacological treatments (dosages, drug's potential side effects , incompatibilities, interactions with other drugs)• Worked collaboratively with health care professionals to devise the most appropriate drug treatment for patients.